ASCO20: Can you describe what characterizes the group of patients with non-metastatic castration-resistant prostate cancer?

Eric J. Small | ASCO20 Virtual | Onkologia ja Hematologia | KESÄKUU 9, 2020

Asiantuntija: Eric J. Small

In this MEDtalk Eric J. Small, MD and principal investigator of the SPARTAN study describe what characterizes the group of patients with nonmetastatic castration-resistant prostate cancer?